ArticleScientific reports2025
Molecular characterization of bovine leukemia virus detected in dairy cattle herds from the Emirate of Abu Dhabi, United Arab Emirates.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances in nanoadsorbents for the efficient removal of nickel ions from aqueous solutions.Biodegradation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Enzootic bovine leukosis (EBL) is an economically important disease of cattle caused by the bovine leukemia virus (BLV). Although BLV-seropositive dairy cattle were previously reported in the Emirate of Dhabi, UAE (EAD), molecular characterization of circulating BLV strains has not been undertaken. Therefore, the objectives of this study were to reassess the seroprevalence along with evaluating the genetic diversity of BLV strains circulating in dairy cattle in the EAD. Sera from 782 dairy cattle distributed across 11 farms were ELISA-screened and RT-qPCR testing of seropositive samples was followed by Sanger sequencing of the partial BLV env-gp51 gene (~ 423 bp) and phylogenetic analysis. The overall BLV herd seroprevalence was 27.3% (CI: 6.03%-61.00%), mean animal seroprevalence 33.5% (CI:30.20%-36.93%), and individual farm seroprevalence 28.00% (CI:19.00%-36.00%), 70.00% (CI:56.00%-84.00%), and 64.00% (59.00%-70.00%) for Farms 7, 11, and 14 respectively. Viral RNA was detected in 107 of 205 (52.2%) seropositive cattle, and phylogenetic analysis revealed a high genetic relatedness (~ 99.3-100.0%) among the BLV strains from the EAD. Additionally, study BLV isolates cluster under BLV-genotype 4 along with strains from Belgium, Russia and Vietnam. BLV infection is confirmed in EAD cattle, with circulating genotype 4 strains closely related to those from Europe and Asia, suggesting potential transboundary connections and underscoring the need for coordinated regional control measures. Future studies should focus on characterizing BLV infection risk factors in dairy cattle farms in the EAD. In the meantime, UAE livestock health authorities should urgently consider developing a national EBL control policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.